EEM vs XBI
iShares MSCI Emerging Markets ETF vs SPDR S&P Biotech ETF
- • XBI has the lower expense ratio at 0.35% vs 0.72% for EEM.
- • EEM pays a higher dividend yield (1.63%).
Side-by-side metrics
| Metric | EEM | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.72% | 0.35% |
Dividend yield Trailing 12-month yield. | 1.63% | 0.36% |
AUM Assets under management — bigger funds are typically more liquid. | $30.32B | $10.73B |
YTD return | 21.67% | 33.79% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 1.03 | 1.10 |
P/E ratio | 17.21 | — |
Last price | $66.78 | $164.28 |
Inception | — | — |
Issuer | iShares | State Street |
EEM top holdings
| 2330.TW | Taiwan Semiconductor Manufacturing Co Ltd | 15.05% |
| 005930.KS | Samsung Electronics Co Ltd | 8.14% |
| 000660.KS | SK Hynix Inc | 7.63% |
| 0700.HK | Tencent Holdings Ltd | 2.73% |
| 9988.HK | Alibaba Group Holding Ltd Ordinary Shares | 1.60% |
| 2454.TW | MediaTek Inc | 1.55% |
| 2308.TW | Delta Electronics Inc | 0.96% |
| 005935 | Samsung Electronics Co Ltd Participating Preferred | 0.89% |
| 402340.KS | SK Square | 0.82% |
| 2317.TW | Hon Hai Precision Industry Co Ltd | 0.78% |
XBI top holdings
| APGE | Apogee Therapeutics Inc | 1.49% |
| MRNA | Moderna Inc | 1.41% |
| TWST | Twist Bioscience Corp | 1.41% |
| ORKA | Oruka Therapeutics Inc | 1.38% |
| KYMR | Kymera Therapeutics Inc Ordinary Shares | 1.36% |
| VKTX | Viking Therapeutics Inc | 1.30% |
| PRAX | Praxis Precision Medicines Inc Ordinary Shares | 1.29% |
| ERAS | Erasca Inc | 1.27% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 1.20% |
| RYTM | Rhythm Pharmaceuticals Inc | 1.20% |
About EEM
EEM (iShares MSCI Emerging Markets ETF) is Liquid emerging-market equities. Managed by iShares, the fund carries $30.3B in assets under management, an expense ratio of 0.72%, a dividend yield of 1.63%. Its largest holding is Taiwan Semiconductor Manufacturing Co Ltd (2330.TW), which represents 15.1% of the portfolio. Real Estate is the fund's largest sector exposure at 0.9%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.7B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.36%. Its largest holding is Apogee Therapeutics Inc (APGE), which represents 1.5% of the portfolio. Financial Services is the fund's largest sector exposure at 0.5%.